Pharmacokinetics of Pavaverine After Intraluminal Administration

NCT01436981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2013-06-04

No results posted yet for this study

Summary

The purpose of this study is to determine the pharmacokinetic of papaverine after administration into the artery mammaria interna.

Conditions

  • Injury of Internal Mammary Artery
  • Complications Due to Coronary Artery Bypass Graft

Interventions

PROCEDURE

CABG

Preparation of artery mammaria interna

Sponsors & Collaborators

  • Klinikum Ludwigshafen

    collaborator OTHER
  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Arndt H Kiessling, MD · Johann Wolfgang Goethe University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01436981 on ClinicalTrials.gov